Hawaii 2026 Regular Session

Hawaii Senate Bill SB851

Introduced
1/17/25  

Caption

Relating To Emergency Response.

Impact

The proposed changes under SB851 intend to modernize the state's emergency medical services protocols and promote comprehensive care during opioid-related emergencies. By enabling EMTs to administer buprenorphine, the bill strives to improve patient outcomes and reduce burdens on healthcare facilities that deal with repetitive emergency visits and hospital readmissions due to opioid overdoses. In doing so, the bill reflects a growing recognition of the need for effective intervention strategies that bridge individuals into treatment services, which could dramatically change the landscape of opioid treatment in Hawaii.

Summary

Senate Bill 851 aims to address the ongoing opioid crisis in Hawaii by authorizing emergency medical technicians (EMTs) to administer buprenorphine after administering an opioid antagonist during overdose responses. The bill emphasizes the necessity of adapting emergency responses to align with national best practices, aiming to decrease the risk of repeat overdoses and enhance the likelihood of long-term recovery for individuals affected by opioid overdose. Currently, emergency responses allow for the administration of opioid antagonists, but this can lead to adverse effects like acute withdrawal symptoms, which the bill seeks to mitigate through the introduction of buprenorphine in the emergency response protocol.

Contention

While the bill positions itself as a necessary response to the escalating opioid crisis, it may encounter opposition based on concerns regarding the training and competency of EMTs in administering buprenorphine. Additionally, debates might arise over the appropriate integration of such practices within existing emergency services without compromising the standards of care. Proponents will likely argue that such measures are essential in combating the opioid crisis, pointing to evidence from other states where similar policies have led to improved treatment connections and reduced overdose deaths.

Companion Bills

HI SB851

Carry Over Relating To Emergency Response.

Previously Filed As

HI SB851

Relating To Emergency Response.

HI HB816

Relating To Emergency Response.

HI SB92

Relating To Emergency Medical Response.

HI HB310

Relating To Opioid Antagonists.

HI HB51

Relating To Emergency Medical Response.

HI SB957

Relating To Overdose Prevention.

HI HB1399

Relating To Opioid Antagonists.

HI SB998

Relating To The Hawaii First Responders Memorial.

HI HB240

Relating To Overdose Prevention.

HI HB503

Relating To The Hawaii First Responders Memorial.

Similar Bills

HI HB816

Relating To Emergency Response.

HI HB816

Relating To Emergency Response.

HI SB851

Relating To Emergency Response.

HI SB2505

Relating To Opioid Use Disorder Treatment.

HI HB2063

Relating To Opioid Use Disorder Treatment.

NM HB505

Opioid Use Disorder Drug Stocks

NM HB137

Stocking Of Certain Drugs In Pharmacies

NJ A4550

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.